Denali Therapeutics
(NASDAQ) DNLI
Denali Therapeutics Financials at a Glance
Market Cap
$3.07B
Revenue (TTM)
$0.00
Net Income (TTM)
$512.54M
EPS (TTM)
$-2.97
P/E Ratio
-6.53
Dividend
$0.00
Beta (Volatility)
1.62 (High)
Dividend
$0.00
Beta (Volatility)
1.62 (High)
Price
$19.38
Volume
67,156
Open
$20.72
Price
$19.38
Volume
67,156
Open
$20.72
Previous Close
$19.38
Daily Range
$19.23 - $20.72
52-Week Range
$10.80 - $23.77
Dividend
$0.00
Beta (Volatility)
1.62 (High)
Price
$19.38
Volume
67,156
Open
$20.72
Previous Close
$19.38
Daily Range
$19.23 - $20.72
52-Week Range
$10.80 - $23.77
DNLI News
DNLI: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Denali Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
503
CEO
Ryan J. Watts, PhD
Website
www.denalitherapeutics.comHeadquarters
South San Francisco, CA 94080, US
DNLI Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-46%
Return on Capital
-53%
Return on Assets
-45%
Earnings Yield
-15.31%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$3.07B
Shares Outstanding
158.59M
Volume
67.16K
Short Interest
0.00%
Avg. Volume
1.80M
Financials (TTM)
Gross Profit
$11.18M
Operating Income
$555.34M
EBITDA
$497.63M
Operating Cash Flow
$412.60M
Capital Expenditure
$9.50M
Free Cash Flow
$422.10M
Cash & ST Invst.
$867.88M
Total Debt
$42.29M
Denali Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$2.87M
N/A
Gross Margin
0.00%
N/A
Market Cap
$3.07B
N/A
Market Cap/Employee
$6.94M
N/A
Employees
443
N/A
Net Income
$128.55M
-12.0%
EBITDA
$124.67M
+2.0%
Quarterly Fundamentals
Net Cash
$825.59M
+5.4%
Accounts Receivable
$2.18M
+0.3%
Inventory
$0.00
N/A
Long Term Debt
$32.74M
-10.7%
Short Term Debt
$9.55M
-20.7%
Return on Assets
-44.77%
N/A
Return on Invested Capital
-53.07%
N/A
Free Cash Flow
$100.06M
-12.7%
Operating Cash Flow
$98.54M
-17.7%